Connecting oncology professionals with relevant clinical trials

Selected clinical trial

EURbG2: A European prospective study of unilateral retinoblastoma requiring enucleation, first-line or after neoadjuvant chemotherapy, with assessment of histological risk factors and biomarkers

Sponsor: Institut Curie

Phase:

Disease: Unilateral retinoblastoma

EU trial number: 2024-515962-15-00

Population: Predominantly pediatric patients with extensive non-familial unilateral intraocular retinoblastoma requiring first-line enucleation (Study A), or advanced unilateral retinoblastoma requiring neoadjuvant chemotherapy before enucleation (Study B), with subsequent risk-adapted adjuvant treatment.

Register Investigator Interest

Interested in offering this trial to suitable patients?